Recent advance of fluorescent probes for detection of drug-induced liver injury markers

被引:21
|
作者
Sun, Dongqin [1 ]
Chen, Zhenzhen [1 ]
Hu, Jiali [1 ]
Zeng, Huajin [1 ]
Qu, Lingbo [2 ]
Yang, Ran [2 ]
机构
[1] Zhengzhou Univ, Sch Pharmaceut Sci, Zhengzhou 450001, Peoples R China
[2] Zhengzhou Univ, Coll Chem, Zhengzhou 450001, Peoples R China
基金
中国国家自然科学基金;
关键词
Fluorescent probe; Drug-induced liver injury (DILI); Roussel uclaf causality assessment method (RUCAM); Clinical markers; Imaging; GLUTATHIONE-S-TRANSFERASE; IMAGING ENDOGENOUS PEROXYNITRITE; HIGHLY SELECTIVE DETECTION; ALANINE AMINOTRANSFERASE; INDUCED HEPATOTOXICITY; ENDOPLASMIC-RETICULUM; BIOLUMINESCENT PROBE; CAUSALITY ASSESSMENT; HYPOCHLOROUS ACID; ADVERSE REACTIONS;
D O I
10.1016/j.cclet.2021.12.043
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Drug-induced liver injury (DILI) is a common and serious adverse drug reaction. At present, DILI is perfectly diagnozed in clinical settings using Roussel Uclaf causality assessment method (RUCAM) in its original version published 1993 and its updated version published 2016, well established worldwide as a diagnostic algorithm with a high sensitivity and specificity. Nevertheless, the search for additional detection methods supporting RUCAM continues. In recent years, with the development of optical imaging technology, fluorescent probes have gradually shown great advantages in the detection and diagnosis of DILI markers such as high sensitivity, anti-interference, real-time monitoring and non-invasive measurement. In this review, the recent advances of fluorescent probes for evaluation of DILI in experimental studies were summarized according to various markers of DILI. We believe that learning about the design and practical application of these probes will contribute to the further development of detection sensors for DILI markers. (C) 2022 Published by Elsevier B.V. on behalf of Chinese Chemical Society and Institute of Materia Medica, Chinese Academy of Medical Sciences.
引用
收藏
页码:4478 / 4494
页数:17
相关论文
共 50 条
  • [21] Drug-induced liver injury: a comprehensive review
    Hosack, Tom
    Damry, Djamil
    Biswas, Sujata
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [22] Identification of proteome markers for drug-induced liver injury in zebrafish embryos
    Driessen, Marja
    van der Plas-Duivesteijn, Suzanne
    Kienhuis, Anne S.
    van den Brandhof, Evert-Jan
    Roodbergen, Marianne
    van de Water, Bob
    Spaink, Herman P.
    Palmblad, Magnus
    van der Ven, Leo T. M.
    Pennings, Jeroen L. A.
    TOXICOLOGY, 2022, 477
  • [23] Drug-induced liver injury: diagnosis of exclusion
    Maev, Igor V.
    Polunina, Tatiana E.
    TERAPEVTICHESKII ARKHIV, 2023, 95 (08) : 611 - 620
  • [24] Drug-Induced Liver Injury in GI Practice
    Sandhu, Naemat
    Navarro, Victor
    HEPATOLOGY COMMUNICATIONS, 2020, 4 (05) : 631 - 645
  • [25] Drug-induced liver injury: Is it somehow foreseeable?
    Tarantino, Giovanni
    Di Minno, Matteo Nicola Dario
    Capone, Domenico
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (23) : 2817 - 2833
  • [26] Activatable Optical Probes for Fluorescence and Photoacoustic Imaging of Drug-Induced Liver Injury
    Chen, Linrong
    Zhen, Xu
    Jiang, Xiqun
    ADVANCED NANOBIOMED RESEARCH, 2022, 2 (12):
  • [27] The transformation in biomarker detection and management of drug-induced liver injury
    Church, Rachel J.
    Watkins, Paul B.
    LIVER INTERNATIONAL, 2017, 37 (11) : 1582 - 1590
  • [28] Drug-induced liver injury in Oncology
    Ricart, A. D.
    ANNALS OF ONCOLOGY, 2017, 28 (08) : 2013 - 2020
  • [29] Pharmacogenetics of Drug-Induced Liver Injury
    Russmann, Stefan
    Jetter, Alexander
    Kullak-Ublick, Gerd A.
    HEPATOLOGY, 2010, 52 (02) : 748 - 761
  • [30] Drug-Induced Liver Injury: Highlights from a Review of the 2015 Literature
    Sarges, Philip
    Steinberg, Joshua M.
    Lewis, James H.
    DRUG SAFETY, 2016, 39 (09) : 801 - 821